Literature DB >> 5060671

The effect of portacaval anastomosis on oral carbohydrate tolerance and on plasma insulin levels.

C D Holdsworth, L Nye, E King.   

Abstract

In patients with portal hypertension, plasma insulin levels were raised both fasting and after oral glucose or intravenous tolbutamide. This supports previous suggestions that resistance to endogenous insulin plays a major role in producing the impaired glucose tolerance found in chronic hepatic dysfunction. The operation of portacaval anastomosis was followed by impaired oral fructose tolerance, but did not significantly change oral glucose tolerance. Plasma insulin levels were unchanged by the operation, either fasting or following the stimulus of an oral glucose load or intravenous tolbutamide. The insulin response after operation was only higher after intensive pancreatic beta cell stimulation by a combination of glucose, tolbutamide, and glucagon. These results indicate that, in patients with hepatic dysfunction, little insulin is being removed by the liver from the portal blood except when the insulin secretory rate is unusually high.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5060671      PMCID: PMC1411965          DOI: 10.1136/gut.13.1.58

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.

Authors:  A S HUGGETT; D A NIXON
Journal:  Lancet       Date:  1957-08-24       Impact factor: 79.321

2.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

3.  Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man.

Authors:  W G Ryan; A F Nibbe; T B Schwartz
Journal:  Lancet       Date:  1967-06-10       Impact factor: 79.321

4.  Glucagon clearance by the isolated perfused rat liver.

Authors:  K D Buchanan; S S Solomon; J E Vance; H P Porter; R H Williams
Journal:  Proc Soc Exp Biol Med       Date:  1968-06

5.  Prolonged survival after portal decompression of patients with non-cirrhotic intrahepatic portal hypertension.

Authors:  R Zeegen; A G Stansfeld; A M Dawson; A H Hunt
Journal:  Gut       Date:  1970-07       Impact factor: 23.059

6.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

7.  The role of the portal circulation in glucose and fructose tolerance.

Authors:  N McIntyre; D S Turner; C D Holdsworth
Journal:  Diabetologia       Date:  1970-12       Impact factor: 10.122

8.  Plasma insulin after diversion of portal and pancreatic venous blood to vena cava.

Authors:  W R Waddell; K E Sussman
Journal:  J Appl Physiol       Date:  1967-04       Impact factor: 3.531

9.  [Colorimetric analysis of keto-hexoses and inulin by means of the thiobarbituric acid reaction. Conditions of the reaction].

Authors:  R Zender; A Falbriard
Journal:  Clin Chim Acta       Date:  1966-02       Impact factor: 3.786

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  6 in total

1.  Portal diversion for the treatment of glycogen storage disease in humans.

Authors:  T E Starzl; C W Putnam; K A Porter; C G Halgrimson; J Corman; B I Brown; R W Gotlin; D O Rodgerson; H L Greene
Journal:  Ann Surg       Date:  1973-10       Impact factor: 12.969

2.  Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.

Authors:  L Gerö; L Korányi; F Szalay; B Büki; G Tamás
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

3.  Insulin resistance is the main determinant of impaired glucose tolerance in patients with liver cirrhosis.

Authors:  G Marchesini; G P Bianchi; G Forlani; A G Rusticali; D Patrono; M Capelli; M Zoli; P Vannini; E Pisi
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

4.  Metabolic handling of orally administered glucose in cirrhosis.

Authors:  Y T Kruszynska; A Meyer-Alber; F Darakhshan; P D Home; N McIntyre
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  Effects of intra- and extrahepatic portal systemic shunts on insulin metabolism.

Authors:  K Ohnishi; A Mishima; M Takashi; S Tsuchiya; S Iida; S Iwama; N Goto; K Kono; Y Nakajima; N Suzuki; H Musha; K Okuda
Journal:  Dig Dis Sci       Date:  1983-03       Impact factor: 3.199

6.  Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.

Authors:  G Smith-Laing; H Orskov; M B Gore; S Sherlock
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.